iCap et LEXI sont déployés sur les six chaînes d’Europe centrale et orientale de CME LONDRES, 04 déc. 2024 (GLOBE NEWSWIRE) — AI-Media, leader mondial en matière de sous-titrage généré par l’IA en direct et en différé et de technologie linguistique, a le plaisir d’annoncer un contrat stratégique de 5
iCap and LEXI roll out to CME’s six Central and Eastern European stations AI-Media and CME Sign 5-Year Agreement LONDON, Dec. 04, 2024 (GLOBE NEWSWIRE) — AI-Media, a global leader in live and recorded AI captioning and language technology, is delighted to announce a strategic 5-year agreement with Central European
Two-day event will preview Mavenir’s strategic initiatives and forward-looking roadmap to invited international audience of analysts, customers and partners RICHARDSON, Texas, Dec. 04, 2024 (GLOBE NEWSWIRE) — Mavenir, the cloud-native network infrastructure provider building the future of networks, will hold its annual analyst event from December 11 – 12, 2024
Two-day event will preview Mavenir’s strategic initiatives and forward-looking roadmap to invited international audience of analysts, customers and partners RICHARDSON, Texas, Dec. 04, 2024 (GLOBE NEWSWIRE) — Mavenir, the cloud-native network infrastructure provider building the future of networks, will hold its annual analyst event from December 11 – 12, 2024
Two-day event will preview Mavenir’s strategic initiatives and forward-looking roadmap to invited international audience of analysts, customers and partners RICHARDSON, Texas, Dec. 04, 2024 (GLOBE NEWSWIRE) — Mavenir, the cloud-native network infrastructure provider building the future of networks, will hold its annual analyst event from December 11 – 12, 2024
LAKE TAHOE, Nev., Dec. 03, 2024 (GLOBE NEWSWIRE) — 2ONE Labs Inc., is pleased to have received ‘Acceptance’ of a second Premarket Tobacco Product Application (PMTA) for additional flavored 2ONE® nicotine product styles submitted to the U.S. Food and Drug Administration (FDA). Welcoming receipt of this additional FDA ‘Acceptance’ notification,
